Literature DB >> 8547058

Aplasia cutis congenita after exposure to methimazole: a causal relationship?

T Vogt1, W Stolz, M Landthaler.   

Abstract

We report a child with scalp aplasia cutis congenita, whose mother was treated with methimazole during pregnancy. The relationship between antithyroid drug administration during pregnancy and the occurrence of scalp defects is discussed, and the pertinent literature is reviewed.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8547058     DOI： 10.1111/j.1365-2133.1995.tb06940.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.

Authors:  E Gianetti; L Russo; F Orlandi; L Chiovato; M Giusti; S Benvenga; M Moleti; F Vermiglio; P E Macchia; M Vitale; C Regalbuto; M Centanni; E Martino; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2015-04-04       Impact factor: 4.256

Review 3.  Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.

Authors:  M Tonacchera; L Chiovato; L Bartalena; A F Cavaliere; P Vitti
Journal:  J Endocrinol Invest       Date:  2019-11-29       Impact factor: 4.256

4.  Aplasia cutis congenita: Two case reports and discussion of the literature.

Authors:  Alexandros Blionas; Dimitrios Giakoumettis; Elias Antoniades; Evangelos Drosos; Andreas Mitsios; Sotirios Plakas; Georgios Sfakianos; Marios S Themistocleous
Journal:  Surg Neurol Int       Date:  2017-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.